AI-driven medical overprescription exposes neoliberal healthcare’s cost-efficiency paradox and algorithmic bias
Original framing: “AI doctors’ orders come with a sky-high bill” — Nature
This phenomenon mirrors past cycles of medical overutilization, such as the 1980s surge in unnecessary C-sections (driven by hospital reimbursement incentives) or the opioid epidemic (fueled by pharmaceutical marketing). Each case reveals how structural incentives—whether fee-for-service models or algorithmic profit signals—create perverse feedback loops. The current AI-driven diagnostic inflation is not a technological anomaly but a predictable outcome of neoliberal healthcare’s core logic, where efficiency is measured by throughput, not patient outcomes.
The AI-driven diagnostic inflation crisis is not a failure of technology but a symptom of healthcare’s neoliberal core: the prioritization of measurable throughput over patient well-being, enabled by perverse incentives and unchecked algorithmic power.
Historical patterns—from opioid overprescription to unnecessary surgeries—reveal this as a recurring cycle of medical industrialization, where innovation is co-opted by corporate actors to extract value. Indigenous and cross-cultural models, like Cuba’s community-based care or Māori *rongoā*, offer viable alternatives but are marginalized in favor of techno-optimist narratives. The trickster dimension exposes the absurdity of treating AI as a neutral tool when its recommendations are shaped by pharmaceutical industry biases and fee-for-service logic. Solutions must address this structurally: through algorithmic impact assessments, Indigenous data governance, and reimbursement reforms that decouple profit from overutilization. Without these systemic shifts, AI will not 'fix' healthcare—it will deepen its inequities.